GLP-1s and GenAI Target Healthcare Costs

Healthcare costs keep rising, and after more than 15 years helping families and business owners secure the right coverage, I see firsthand how these trends affect real people. Two promising tools are emerging: GLP-1 medications—shown to help with obesity prevention and slow chronic disease—and generative AI, which can support more continuous, proactive care. For many of my Medicare and ACA clients managing chronic illness, innovations like home monitors connected to clinician-supervised AI could mean earlier intervention and better outcomes. There's talk of expanding GLP-1 access through federal programs and making it easier to integrate home health data with AI for smarter care. With national healthcare spending projected to reach $9 trillion by 2034, it’s never been more important to understand your options and stay informed about how new technologies might impact your coverage and out-of-pocket costs. My goal is always to help you protect your future and make confident choices about your health and finances—because informed decisions today can make all the difference tomorrow.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *